The neuropsychopharmacology of cannabis:a review of human imaging studies

Autor: Matthew B. Wall, Sebastian F. Green, Katherine Petrilli, M Olabisi Ogunbiyi, Michael A P Bloomfield, Tom P. Freeman, Matthijs G. Bossong, Harry Costello, Rachel Lees, Chandni Hindocha

Publikováno v: Bloomfield, M A P, Hindocha, C, Green, S F, Wall, M B, Lees, R, Petrilli, K, Costello, H, Olabisi Ogunbiyi, M, Bossong, M G & Freeman, T P 2018, ' The neuropsychopharmacology of cannabis : a review of human imaging studies ', Pharmacology and Therapeutics . https://doi.org/10.1016/j.pharmthera.2018.10.006
Pharmacology & Therapeutics
Pharmacology & Therapeutics, 195, 132. Elsevier Inc.
Bloomfield, M A P, Hindocha, C, Green, S F, Wall, M B, Lees, R, Petrilli, K, Costello, H, Olabisi Ogunbiyi, M, Bossong, M G & Freeman, T P 2018, ' The neuropsychopharmacology of cannabis: a review of human imaging studies ', Pharmacology and Therapeutics . https://doi.org/10.1016/j.pharmthera.2018.10.006

The laws governing cannabis are evolving worldwide and associated with changing patterns of use. The main psychoactive drug in cannabis is Δ9-tetrahydrocannabinol (THC), a partial agonist at the endocannabinoid CB1 receptor. Acutely, cannabis and TH

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f265df89418f7bab5ca3ea4ecff9927
https://kclpure.kcl.ac.uk/ws/files/102173976/The_neuropsychopharmacology_of_cannabis_BLOOMFIELD_Firstonline19October2018_GOLD_AAM_CC_BY_.pdf